The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.
Diabetic Neuropathy, Painful
The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.
PDN Post Market, Multicenter, Prospective, Global Clinical Study
-
Neuroversion, Inc., Anchorage, Alaska, United States, 99508
Michigan Pain Specialists, Ann Arbor, Michigan, United States, 48108
Henry Ford Health, West Bloomfield, Michigan, United States, 48322
Ohio State University Wexner Medical Center, Columbus, Ohio, United States, 43210
Clinical Investigations, LLC, Edmond, Oklahoma, United States, 73013
Columbia Pain Management, Milwaukie, Oregon, United States, 97222
WellSpan Interventional Pain Specialists, York, Pennsylvania, United States, 17402
Virginia Interventional Pain & Spine Centers, Roanoke, Virginia, United States, 24018
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Nevro Corp,
David Caraway, MD, STUDY_DIRECTOR, Chief Medical Officer, Nevro Corp
2028-10